

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.13236806 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.54428958 |
| 3 | positive thymic T cell selection (GO:0045059) | 4.50736178 |
| 4 | detection of other organism (GO:0098543) | 4.31429349 |
| 5 | detection of bacterium (GO:0016045) | 4.29929734 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.28390783 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28390783 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22443195 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.19730880 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.17838697 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17838697 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15441016 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14335271 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.10501587 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.09513793 |
| 16 | embryonic process involved in female pregnancy (GO:0060136) | 4.03109654 |
| 17 | interferon-gamma production (GO:0032609) | 3.81566821 |
| 18 | negative regulation of T cell mediated immunity (GO:0002710) | 3.78486959 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68918072 |
| 20 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.65353255 |
| 21 | activated T cell proliferation (GO:0050798) | 3.64792699 |
| 22 | thymic T cell selection (GO:0045061) | 3.62602096 |
| 23 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.62338733 |
| 24 | negative regulation of granulocyte differentiation (GO:0030853) | 3.54853452 |
| 25 | cellular extravasation (GO:0045123) | 3.53987424 |
| 26 | morphogenesis of an endothelium (GO:0003159) | 3.52868418 |
| 27 | endothelial tube morphogenesis (GO:0061154) | 3.52868418 |
| 28 | positive T cell selection (GO:0043368) | 3.52239959 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.48444618 |
| 30 | T cell migration (GO:0072678) | 3.47920325 |
| 31 | negative T cell selection (GO:0043383) | 3.47706352 |
| 32 | neutrophil activation (GO:0042119) | 3.46931561 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.43021225 |
| 34 | response to peptidoglycan (GO:0032494) | 3.40822017 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.38692324 |
| 36 | tolerance induction (GO:0002507) | 3.36376104 |
| 37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.31922995 |
| 38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.31239829 |
| 39 | respiratory burst (GO:0045730) | 3.29971398 |
| 40 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27334659 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.24943137 |
| 42 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23440586 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23422271 |
| 44 | T cell selection (GO:0045058) | 3.22069273 |
| 45 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18978579 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18978579 |
| 47 | negative regulation of stress fiber assembly (GO:0051497) | 3.15861084 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.15697073 |
| 49 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14713575 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.12166076 |
| 51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10384006 |
| 52 | response to host immune response (GO:0052572) | 3.10384006 |
| 53 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09793912 |
| 54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09793912 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09394346 |
| 56 | granulocyte activation (GO:0036230) | 3.09359407 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.06760520 |
| 58 | defense response to protozoan (GO:0042832) | 3.05316748 |
| 59 | cellular response to type I interferon (GO:0071357) | 3.05125942 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.05125942 |
| 61 | T cell homeostasis (GO:0043029) | 3.04893007 |
| 62 | response to type I interferon (GO:0034340) | 3.04573423 |
| 63 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.02593226 |
| 64 | viral transcription (GO:0019083) | 3.02064531 |
| 65 | negative regulation of interleukin-12 production (GO:0032695) | 3.02036006 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01986063 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.01780619 |
| 68 | regulation of integrin activation (GO:0033623) | 3.01392982 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.00603556 |
| 70 | negative regulation of innate immune response (GO:0045824) | 3.00199690 |
| 71 | response to host (GO:0075136) | 2.96404925 |
| 72 | response to host defenses (GO:0052200) | 2.96404925 |
| 73 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.96404925 |
| 74 | detection of biotic stimulus (GO:0009595) | 2.94638376 |
| 75 | response to interleukin-15 (GO:0070672) | 2.92767165 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 2.90331678 |
| 77 | embryonic placenta development (GO:0001892) | 2.89950476 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89770044 |
| 79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.89310305 |
| 80 | macrophage activation (GO:0042116) | 2.89111451 |
| 81 | leukocyte degranulation (GO:0043299) | 2.88605432 |
| 82 | * response to laminar fluid shear stress (GO:0034616) | 2.87860411 |
| 83 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.86903993 |
| 84 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85838027 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85619307 |
| 86 | regulation of chemokine secretion (GO:0090196) | 2.84646230 |
| 87 | lymphocyte homeostasis (GO:0002260) | 2.84526911 |
| 88 | regulation of gene silencing by RNA (GO:0060966) | 2.84310702 |
| 89 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.84310702 |
| 90 | regulation of gene silencing by miRNA (GO:0060964) | 2.84310702 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 2.83379561 |
| 92 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.82216720 |
| 93 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82090852 |
| 94 | leukocyte aggregation (GO:0070486) | 2.81795127 |
| 95 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81647876 |
| 96 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.81219270 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80481469 |
| 98 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.79715664 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79615804 |
| 100 | negative regulation of type 2 immune response (GO:0002829) | 2.78437904 |
| 101 | translational termination (GO:0006415) | 2.77537545 |
| 102 | negative regulation of bone resorption (GO:0045779) | 2.77199824 |
| 103 | leukocyte cell-cell adhesion (GO:0007159) | 2.76849879 |
| 104 | endothelial cell chemotaxis (GO:0035767) | 2.75495365 |
| 105 | trophectodermal cell differentiation (GO:0001829) | 2.75491479 |
| 106 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75304167 |
| 107 | mature B cell differentiation (GO:0002335) | 2.71464451 |
| 108 | positive regulation by host of viral transcription (GO:0043923) | 2.68345341 |
| 109 | germinal center formation (GO:0002467) | 2.65583316 |
| 110 | immunoglobulin mediated immune response (GO:0016064) | 2.63922123 |
| 111 | ribosomal small subunit biogenesis (GO:0042274) | 2.63776829 |
| 112 | definitive hemopoiesis (GO:0060216) | 2.63121595 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.62661291 |
| 114 | establishment of endothelial barrier (GO:0061028) | 2.62429981 |
| 115 | positive regulation of chemokine secretion (GO:0090197) | 2.58270560 |
| 116 | regulation of tolerance induction (GO:0002643) | 2.58195137 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 2.56093239 |
| 118 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.54345968 |
| 119 | negative regulation of phagocytosis (GO:0050765) | 2.53748241 |
| 120 | regulation of histone H3-K27 methylation (GO:0061085) | 2.53187379 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.51873015 |
| 122 | cellular response to zinc ion (GO:0071294) | 2.51640095 |
| 123 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.50981015 |
| 124 | regulation of antigen processing and presentation (GO:0002577) | 2.50339018 |
| 125 | NIK/NF-kappaB signaling (GO:0038061) | 2.48086272 |
| 126 | leukocyte tethering or rolling (GO:0050901) | 2.44649828 |
| 127 | nodal signaling pathway (GO:0038092) | 2.43315290 |
| 128 | histone H4-K12 acetylation (GO:0043983) | 2.43313647 |
| 129 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.43176809 |
| 130 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43121949 |
| 131 | lymph vessel development (GO:0001945) | 2.42577891 |
| 132 | microglial cell activation (GO:0001774) | 2.42409342 |
| 133 | determination of adult lifespan (GO:0008340) | 2.41415272 |
| 134 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.40528852 |
| 135 | positive regulation of isotype switching (GO:0045830) | 2.40347185 |
| 136 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39686723 |
| 137 | modulation by symbiont of host defense response (GO:0052031) | 2.39686723 |
| 138 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39686723 |
| 139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39686723 |
| 140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39686723 |
| 141 | modulation by symbiont of host immune response (GO:0052553) | 2.39686723 |
| 142 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39261485 |
| 143 | apoptotic process involved in morphogenesis (GO:0060561) | 2.38959063 |
| 144 | positive regulation of histone deacetylation (GO:0031065) | 2.38571090 |
| 145 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.38499165 |
| 146 | regulation of response to interferon-gamma (GO:0060330) | 2.38028653 |
| 147 | macrophage activation involved in immune response (GO:0002281) | 2.37607233 |
| 148 | angiogenesis involved in wound healing (GO:0060055) | 2.37333554 |
| 149 | T cell costimulation (GO:0031295) | 2.36723066 |
| 150 | natural killer cell differentiation (GO:0001779) | 2.36375655 |
| 151 | B cell mediated immunity (GO:0019724) | 2.36034879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59511872 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.55424281 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.43574721 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.31305124 |
| 5 | * KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.10917479 |
| 6 | * KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.10917479 |
| 7 | * KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.10917479 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98902538 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.96833548 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93291976 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54592905 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.37632845 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.35936548 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34578820 |
| 15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30754396 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27633421 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26388002 |
| 18 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19786228 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17619300 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17048078 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16208872 |
| 22 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.09721655 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07719073 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07272835 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05044727 |
| 26 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02551943 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00995107 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.00388290 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.00220876 |
| 30 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99160804 |
| 31 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96349794 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93608422 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 1.93223296 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90822179 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90025909 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88722956 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88688084 |
| 38 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.88523220 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85292946 |
| 40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80172116 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77278897 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70215402 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70046349 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69350094 |
| 45 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69335415 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68569357 |
| 47 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.67133089 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65587248 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63866319 |
| 50 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.61075285 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.60033653 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58683343 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51046009 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.50351720 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50203583 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49854455 |
| 57 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.46580077 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46320606 |
| 59 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45178913 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40946493 |
| 61 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37702015 |
| 62 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33952009 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33098485 |
| 64 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32678334 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31856930 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30212171 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30172295 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29093186 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27988693 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27487235 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24323953 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24274280 |
| 73 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23222744 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21392727 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19812885 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19121592 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17816040 |
| 78 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.16762996 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16598250 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15603061 |
| 81 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.14888622 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14844396 |
| 83 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14184479 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13949516 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13907278 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10004968 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08571705 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06725323 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06660028 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06453001 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06236536 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05793420 |
| 93 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04797241 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04391430 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03837056 |
| 96 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02949336 |
| 97 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01333350 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01114613 |
| 99 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01007881 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00218638 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00025289 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98481298 |
| 103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98386360 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98275092 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98007762 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97537265 |
| 107 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96520822 |
| 108 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95889509 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95869490 |
| 110 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95799465 |
| 111 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94608180 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94018365 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93880103 |
| 114 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93840390 |
| 115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92913302 |
| 116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91989859 |
| 117 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91471507 |
| 118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91165771 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90911449 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90699117 |
| 121 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90450886 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90275634 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90212160 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90030574 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89201192 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89162892 |
| 127 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.88715432 |
| 128 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87849996 |
| 129 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87297822 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85503410 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85353237 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84522090 |
| 133 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.82426085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.22388277 |
| 2 | MP0003724_increased_susceptibility_to | 2.68512446 |
| 3 | MP0003303_peritoneal_inflammation | 2.64250668 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.63522768 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.57627653 |
| 6 | MP0000685_abnormal_immune_system | 2.56973938 |
| 7 | * MP0001800_abnormal_humoral_immune | 2.54251990 |
| 8 | MP0005671_abnormal_response_to | 2.42271953 |
| 9 | MP0001790_abnormal_immune_system | 2.37381291 |
| 10 | MP0005387_immune_system_phenotype | 2.37381291 |
| 11 | MP0003828_pulmonary_edema | 2.28091228 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.22762379 |
| 13 | MP0006082_CNS_inflammation | 2.16839667 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.09429843 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.08530503 |
| 16 | * MP0001819_abnormal_immune_cell | 2.05586371 |
| 17 | MP0002405_respiratory_system_inflammati | 2.05390815 |
| 18 | * MP0002723_abnormal_immune_serum | 2.04307299 |
| 19 | * MP0002398_abnormal_bone_marrow | 1.97278817 |
| 20 | MP0003436_decreased_susceptibility_to | 1.97096116 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.92440473 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.92287433 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.92287433 |
| 24 | MP0002396_abnormal_hematopoietic_system | 1.90683886 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.88112953 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.85064083 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.83108318 |
| 28 | MP0001873_stomach_inflammation | 1.81564215 |
| 29 | * MP0000716_abnormal_immune_system | 1.78521840 |
| 30 | MP0002722_abnormal_immune_system | 1.76364587 |
| 31 | MP0005025_abnormal_response_to | 1.72411711 |
| 32 | MP0002419_abnormal_innate_immunity | 1.69491842 |
| 33 | MP0002009_preneoplasia | 1.68883652 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.68836571 |
| 35 | MP0004510_myositis | 1.68383751 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.66097339 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.63547017 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.59166030 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.58106587 |
| 40 | MP0004381_abnormal_hair_follicle | 1.56271374 |
| 41 | MP0008057_abnormal_DNA_replication | 1.56026916 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.55925263 |
| 43 | * MP0002429_abnormal_blood_cell | 1.55001863 |
| 44 | MP0008260_abnormal_autophagy | 1.53553018 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.52049363 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.50930062 |
| 47 | MP0002006_tumorigenesis | 1.48438531 |
| 48 | MP0001879_abnormal_lymphatic_vessel | 1.45935260 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.44548037 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.43379625 |
| 51 | MP0003448_altered_tumor_morphology | 1.43008388 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.41785863 |
| 53 | MP0009785_altered_susceptibility_to | 1.39878693 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.38085595 |
| 55 | MP0005023_abnormal_wound_healing | 1.37789911 |
| 56 | MP0004947_skin_inflammation | 1.37259979 |
| 57 | MP0000490_abnormal_crypts_of | 1.34446501 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.34154066 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.29914010 |
| 60 | MP0001851_eye_inflammation | 1.27946270 |
| 61 | MP0001853_heart_inflammation | 1.23615201 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.22862369 |
| 63 | MP0002933_joint_inflammation | 1.20954642 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.20856291 |
| 65 | MP0000858_altered_metastatic_potential | 1.14030267 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.13424662 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.12317320 |
| 68 | MP0002254_reproductive_system_inflammat | 1.08411553 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.06384847 |
| 70 | MP0004130_abnormal_muscle_cell | 1.04378208 |
| 71 | MP0009764_decreased_sensitivity_to | 1.03144520 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.01590468 |
| 73 | MP0008995_early_reproductive_senescence | 1.01285447 |
| 74 | MP0000249_abnormal_blood_vessel | 0.99838992 |
| 75 | MP0000343_altered_response_to | 0.99745027 |
| 76 | MP0003183_abnormal_peptide_metabolism | 0.97946957 |
| 77 | MP0003077_abnormal_cell_cycle | 0.97620715 |
| 78 | MP0005451_abnormal_body_composition | 0.96893155 |
| 79 | MP0005164_abnormal_response_to | 0.94590406 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.94394735 |
| 81 | MP0002132_abnormal_respiratory_system | 0.94162776 |
| 82 | MP0003866_abnormal_defecation | 0.93257365 |
| 83 | MP0001663_abnormal_digestive_system | 0.92951906 |
| 84 | MP0002925_abnormal_cardiovascular_devel | 0.92545908 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.91879644 |
| 86 | * MP0002086_abnormal_extraembryonic_tissu | 0.91605877 |
| 87 | MP0002928_abnormal_bile_duct | 0.90700092 |
| 88 | MP0004883_abnormal_blood_vessel | 0.89328751 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.88799135 |
| 90 | MP0003705_abnormal_hypodermis_morpholog | 0.86869557 |
| 91 | * MP0000767_abnormal_smooth_muscle | 0.86242930 |
| 92 | MP0010094_abnormal_chromosome_stability | 0.85872241 |
| 93 | MP0003091_abnormal_cell_migration | 0.85768107 |
| 94 | MP0005166_decreased_susceptibility_to | 0.85410627 |
| 95 | MP0008004_abnormal_stomach_pH | 0.83483839 |
| 96 | MP0000350_abnormal_cell_proliferation | 0.83094024 |
| 97 | MP0001915_intracranial_hemorrhage | 0.82180838 |
| 98 | MP0005670_abnormal_white_adipose | 0.81777142 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.81518192 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.79786048 |
| 101 | MP0008469_abnormal_protein_level | 0.79491547 |
| 102 | MP0004957_abnormal_blastocyst_morpholog | 0.78997043 |
| 103 | MP0005390_skeleton_phenotype | 0.77369591 |
| 104 | MP0003690_abnormal_glial_cell | 0.77233273 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.75945530 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.75697521 |
| 107 | MP0003045_fibrosis | 0.75372348 |
| 108 | * MP0003279_aneurysm | 0.75300899 |
| 109 | MP0003786_premature_aging | 0.74502383 |
| 110 | MP0003136_yellow_coat_color | 0.74372206 |
| 111 | MP0005310_abnormal_salivary_gland | 0.72949666 |
| 112 | MP0003075_altered_response_to | 0.72875633 |
| 113 | MP0009763_increased_sensitivity_to | 0.72078979 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.68477312 |
| 115 | MP0006054_spinal_hemorrhage | 0.68356202 |
| 116 | * MP0001614_abnormal_blood_vessel | 0.67518385 |
| 117 | * MP0002088_abnormal_embryonic_growth/wei | 0.66747738 |
| 118 | MP0003795_abnormal_bone_structure | 0.65709254 |
| 119 | MP0004484_altered_response_of | 0.60953518 |
| 120 | MP0008874_decreased_physiological_sensi | 0.57263884 |
| 121 | MP0009840_abnormal_foam_cell | 0.55802398 |
| 122 | MP0002133_abnormal_respiratory_system | 0.54476338 |
| 123 | MP0005388_respiratory_system_phenotype | 0.54476338 |
| 124 | MP0001958_emphysema | 0.53949289 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.53908741 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.51160525 |
| 127 | MP0009115_abnormal_fat_cell | 0.49427092 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.45759495 |
| 129 | MP0000604_amyloidosis | 0.44638717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.67387869 |
| 2 | Spontaneous hematomas (HP:0007420) | 4.18332659 |
| 3 | Pustule (HP:0200039) | 4.16830279 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.09870462 |
| 5 | Optic neuritis (HP:0100653) | 4.07682560 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.07682560 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 3.93920824 |
| 8 | Abnormality of the nasal mucosa (HP:0000433) | 3.93481421 |
| 9 | Hematochezia (HP:0002573) | 3.68869898 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.61934037 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.55565950 |
| 12 | Nasal polyposis (HP:0100582) | 3.51239979 |
| 13 | Encephalitis (HP:0002383) | 3.47951381 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.43042513 |
| 15 | Glomerulonephritis (HP:0000099) | 3.30074324 |
| 16 | Colitis (HP:0002583) | 3.28802409 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.21540131 |
| 18 | IgM deficiency (HP:0002850) | 3.20112221 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.17492292 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12330091 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.10376689 |
| 22 | Hypochromic microcytic anemia (HP:0004840) | 3.08913219 |
| 23 | Cellulitis (HP:0100658) | 3.03353472 |
| 24 | Gingivitis (HP:0000230) | 3.02163957 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 3.00054471 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 2.99902634 |
| 27 | Pulmonary infiltrates (HP:0002113) | 2.94859747 |
| 28 | Granulocytopenia (HP:0001913) | 2.88556523 |
| 29 | Urticaria (HP:0001025) | 2.85172947 |
| 30 | T lymphocytopenia (HP:0005403) | 2.84489348 |
| 31 | Recurrent viral infections (HP:0004429) | 2.83754258 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80596667 |
| 33 | Keratoconjunctivitis (HP:0001096) | 2.76755320 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.75452628 |
| 35 | Prolonged bleeding time (HP:0003010) | 2.71181115 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.68710069 |
| 37 | Papilledema (HP:0001085) | 2.67613194 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.65051628 |
| 39 | Myositis (HP:0100614) | 2.64839335 |
| 40 | Episodic fever (HP:0001954) | 2.62763072 |
| 41 | Aortic aneurysm (HP:0004942) | 2.62586244 |
| 42 | Intestinal fistula (HP:0100819) | 2.56394592 |
| 43 | Abnormality of T cells (HP:0002843) | 2.55979449 |
| 44 | Chronic otitis media (HP:0000389) | 2.55131648 |
| 45 | Stomatitis (HP:0010280) | 2.48764353 |
| 46 | Pulmonary embolism (HP:0002204) | 2.48715732 |
| 47 | Gingival bleeding (HP:0000225) | 2.47415083 |
| 48 | Emphysema (HP:0002097) | 2.45447189 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.44576538 |
| 50 | Abnormality of the fingertips (HP:0001211) | 2.40990976 |
| 51 | Osteomyelitis (HP:0002754) | 2.38979817 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.36460650 |
| 53 | Meningitis (HP:0001287) | 2.35943595 |
| 54 | Microcytic anemia (HP:0001935) | 2.33924790 |
| 55 | Basal cell carcinoma (HP:0002671) | 2.30932994 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.30406758 |
| 57 | Sepsis (HP:0100806) | 2.30357295 |
| 58 | Slow saccadic eye movements (HP:0000514) | 2.29447587 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.27655794 |
| 60 | Reticulocytopenia (HP:0001896) | 2.27092768 |
| 61 | Anorexia (HP:0002039) | 2.26979773 |
| 62 | Urethral obstruction (HP:0000796) | 2.25682239 |
| 63 | Rectal fistula (HP:0100590) | 2.24289460 |
| 64 | Rectovaginal fistula (HP:0000143) | 2.24289460 |
| 65 | Polycythemia (HP:0001901) | 2.22401198 |
| 66 | Spondylolisthesis (HP:0003302) | 2.21573947 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.20930114 |
| 68 | Petechiae (HP:0000967) | 2.18985688 |
| 69 | Obstructive lung disease (HP:0006536) | 2.16861292 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16861292 |
| 71 | Arterial tortuosity (HP:0005116) | 2.15297868 |
| 72 | Nephritis (HP:0000123) | 2.15032596 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15002615 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15002615 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.14806344 |
| 76 | Lymphopenia (HP:0001888) | 2.12223062 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.10777477 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10230163 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.09681199 |
| 80 | Leukocytosis (HP:0001974) | 2.06219551 |
| 81 | Peritonitis (HP:0002586) | 2.06185172 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.06011735 |
| 83 | Papilloma (HP:0012740) | 2.04444922 |
| 84 | Verrucae (HP:0200043) | 2.04444922 |
| 85 | Dysostosis multiplex (HP:0000943) | 2.04313429 |
| 86 | Obstructive sleep apnea (HP:0002870) | 2.03897988 |
| 87 | Viral hepatitis (HP:0006562) | 2.02477560 |
| 88 | Purpura (HP:0000979) | 2.02335890 |
| 89 | Vasculitis (HP:0002633) | 2.01764762 |
| 90 | Stomach cancer (HP:0012126) | 2.01622684 |
| 91 | Cheilitis (HP:0100825) | 2.01320179 |
| 92 | Restrictive lung disease (HP:0002091) | 2.00507247 |
| 93 | Increased IgE level (HP:0003212) | 1.99539610 |
| 94 | Epistaxis (HP:0000421) | 1.99179662 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 1.96669939 |
| 96 | Vascular tortuosity (HP:0004948) | 1.96421202 |
| 97 | Glomerulopathy (HP:0100820) | 1.94611678 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.93608139 |
| 99 | Recurrent skin infections (HP:0001581) | 1.93137482 |
| 100 | Amyloidosis (HP:0011034) | 1.92361311 |
| 101 | Vaginal fistula (HP:0004320) | 1.91655940 |
| 102 | Agnosia (HP:0010524) | 1.91483432 |
| 103 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91105379 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91105379 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91105379 |
| 106 | Rib fusion (HP:0000902) | 1.90709457 |
| 107 | Eosinophilia (HP:0001880) | 1.88317448 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88278537 |
| 109 | Orchitis (HP:0100796) | 1.87081842 |
| 110 | Recurrent sinusitis (HP:0011108) | 1.86985249 |
| 111 | Abnormality of complement system (HP:0005339) | 1.86574105 |
| 112 | IgA deficiency (HP:0002720) | 1.86201282 |
| 113 | Polygenic inheritance (HP:0010982) | 1.85850539 |
| 114 | Gangrene (HP:0100758) | 1.85279952 |
| 115 | Increased IgM level (HP:0003496) | 1.85030071 |
| 116 | Increased serum ferritin (HP:0003281) | 1.84595991 |
| 117 | Lymphoma (HP:0002665) | 1.84477069 |
| 118 | Thrombocytosis (HP:0001894) | 1.84142671 |
| 119 | Complement deficiency (HP:0004431) | 1.82735375 |
| 120 | Combined immunodeficiency (HP:0005387) | 1.82307237 |
| 121 | Hemoptysis (HP:0002105) | 1.80984778 |
| 122 | Disproportionate tall stature (HP:0001519) | 1.80762806 |
| 123 | Premature loss of primary teeth (HP:0006323) | 1.80624222 |
| 124 | Aortic dissection (HP:0002647) | 1.80507722 |
| 125 | Joint swelling (HP:0001386) | 1.79283729 |
| 126 | Mitral valve prolapse (HP:0001634) | 1.78903031 |
| 127 | Joint stiffness (HP:0001387) | 1.78385309 |
| 128 | Alveolar cell carcinoma (HP:0006519) | 1.78290640 |
| 129 | Bronchitis (HP:0012387) | 1.77113502 |
| 130 | Myocardial infarction (HP:0001658) | 1.76755259 |
| 131 | Chest pain (HP:0100749) | 1.76040394 |
| 132 | Skin ulcer (HP:0200042) | 1.75866917 |
| 133 | Bicuspid aortic valve (HP:0001647) | 1.75857906 |
| 134 | IgG deficiency (HP:0004315) | 1.74079810 |
| 135 | Adactyly (HP:0009776) | 1.72301583 |
| 136 | Asplenia (HP:0001746) | 1.72165155 |
| 137 | Hypochromic anemia (HP:0001931) | 1.71353594 |
| 138 | Abnormality of eosinophils (HP:0001879) | 1.70604876 |
| 139 | Arterial thrombosis (HP:0004420) | 1.70394461 |
| 140 | Interstitial pulmonary disease (HP:0006530) | 1.70025900 |
| 141 | Distal lower limb muscle weakness (HP:0009053) | 1.70020448 |
| 142 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68797697 |
| 143 | Chronic diarrhea (HP:0002028) | 1.68031771 |
| 144 | Leukopenia (HP:0001882) | 1.67794746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.38505192 |
| 2 | MAP4K1 | 4.26782963 |
| 3 | RIPK4 | 3.83906445 |
| 4 | MAPK15 | 3.66970003 |
| 5 | PRPF4B | 3.17302462 |
| 6 | STK10 | 3.09683176 |
| 7 | CDK12 | 2.53642753 |
| 8 | BLK | 2.40556659 |
| 9 | TNK2 | 2.31331103 |
| 10 | GRK6 | 2.30186518 |
| 11 | MAP3K10 | 2.16897213 |
| 12 | CSK | 2.10134725 |
| 13 | TYK2 | 2.03898348 |
| 14 | KDR | 2.01964054 |
| 15 | TIE1 | 1.87753428 |
| 16 | SIK3 | 1.79863659 |
| 17 | ITK | 1.79682212 |
| 18 | TXK | 1.77217203 |
| 19 | MAP3K14 | 1.75071538 |
| 20 | TAOK3 | 1.68500468 |
| 21 | ZAP70 | 1.59096826 |
| 22 | IRAK3 | 1.57631455 |
| 23 | TSSK6 | 1.55613332 |
| 24 | CSF1R | 1.55580075 |
| 25 | NLK | 1.52152733 |
| 26 | ERN1 | 1.49528497 |
| 27 | PIM1 | 1.48227466 |
| 28 | JAK3 | 1.48187099 |
| 29 | PRKD2 | 1.44468782 |
| 30 | IRAK4 | 1.42767449 |
| 31 | IKBKB | 1.35965781 |
| 32 | GRK7 | 1.34133998 |
| 33 | TAOK1 | 1.33137957 |
| 34 | BTK | 1.31206550 |
| 35 | MAP2K3 | 1.24766153 |
| 36 | MARK3 | 1.24487124 |
| 37 | CLK1 | 1.22354931 |
| 38 | MARK2 | 1.21899427 |
| 39 | IKBKE | 1.20521743 |
| 40 | TBK1 | 1.19828185 |
| 41 | EEF2K | 1.18182251 |
| 42 | MAPK7 | 1.15937426 |
| 43 | MAP2K2 | 1.14373160 |
| 44 | HCK | 1.13286500 |
| 45 | SIK1 | 1.12474313 |
| 46 | JAK1 | 1.10723998 |
| 47 | LCK | 1.09244017 |
| 48 | TEC | 1.08872790 |
| 49 | LRRK2 | 1.08301428 |
| 50 | PASK | 1.05087918 |
| 51 | FGFR4 | 1.02273096 |
| 52 | MAP3K7 | 1.02017911 |
| 53 | EPHB1 | 1.00230952 |
| 54 | MAP3K1 | 1.00031668 |
| 55 | RPS6KA4 | 0.98347423 |
| 56 | MST4 | 0.96844449 |
| 57 | MATK | 0.94891922 |
| 58 | FGR | 0.93193636 |
| 59 | CAMKK1 | 0.91940241 |
| 60 | RPS6KB2 | 0.90489325 |
| 61 | PAK4 | 0.90466844 |
| 62 | EPHA2 | 0.89469106 |
| 63 | CDK4 | 0.85810020 |
| 64 | PDK1 | 0.85240483 |
| 65 | FGFR3 | 0.83056452 |
| 66 | MAPK12 | 0.81931639 |
| 67 | CDC42BPA | 0.80906944 |
| 68 | TGFBR1 | 0.79522771 |
| 69 | SMG1 | 0.78542330 |
| 70 | NME2 | 0.78367893 |
| 71 | CDK6 | 0.77439677 |
| 72 | IRAK1 | 0.76986267 |
| 73 | MAP3K3 | 0.76889296 |
| 74 | PKN2 | 0.75460716 |
| 75 | CHUK | 0.75196983 |
| 76 | PRKCQ | 0.72700354 |
| 77 | BMPR2 | 0.72684543 |
| 78 | YES1 | 0.72302969 |
| 79 | CAMK1D | 0.71567232 |
| 80 | SYK | 0.70951457 |
| 81 | GRK1 | 0.68958546 |
| 82 | LYN | 0.68101335 |
| 83 | CAMKK2 | 0.67784038 |
| 84 | RPS6KA6 | 0.67605302 |
| 85 | MELK | 0.67377028 |
| 86 | TYRO3 | 0.67302847 |
| 87 | JAK2 | 0.66400128 |
| 88 | RPS6KL1 | 0.66242627 |
| 89 | RPS6KC1 | 0.66242627 |
| 90 | MAPKAPK3 | 0.66016488 |
| 91 | TTN | 0.64714025 |
| 92 | DYRK1B | 0.64393732 |
| 93 | IRAK2 | 0.64224752 |
| 94 | TAOK2 | 0.63381986 |
| 95 | ALK | 0.62605050 |
| 96 | BMX | 0.62284802 |
| 97 | KSR2 | 0.62272557 |
| 98 | KIT | 0.60743313 |
| 99 | CDK7 | 0.60211631 |
| 100 | PTK6 | 0.60024405 |
| 101 | PDPK1 | 0.59717802 |
| 102 | MAP3K13 | 0.59129922 |
| 103 | HIPK2 | 0.59047170 |
| 104 | CDK9 | 0.57686230 |
| 105 | FYN | 0.57432877 |
| 106 | VRK1 | 0.56985142 |
| 107 | GSK3A | 0.55879440 |
| 108 | ICK | 0.55164518 |
| 109 | MAP3K11 | 0.54422597 |
| 110 | PDK2 | 0.54214948 |
| 111 | SIK2 | 0.52650518 |
| 112 | MAPKAPK2 | 0.52389788 |
| 113 | PRKG2 | 0.51957780 |
| 114 | DYRK3 | 0.51305906 |
| 115 | NEK2 | 0.51293303 |
| 116 | SGK3 | 0.50226032 |
| 117 | PTK2B | 0.50154715 |
| 118 | PRKD1 | 0.50053078 |
| 119 | STK4 | 0.50035947 |
| 120 | FES | 0.48392467 |
| 121 | TESK2 | 0.46930402 |
| 122 | TRIB3 | 0.46802347 |
| 123 | RIPK1 | 0.45833678 |
| 124 | STK38 | 0.45669086 |
| 125 | MAPK4 | 0.43672132 |
| 126 | PIK3CG | 0.43176893 |
| 127 | STK11 | 0.42991351 |
| 128 | BRD4 | 0.42880114 |
| 129 | INSR | 0.42631870 |
| 130 | MAP3K6 | 0.41866321 |
| 131 | RET | 0.39921707 |
| 132 | ACVR1B | 0.38091146 |
| 133 | PRKCH | 0.37050324 |
| 134 | CAMK4 | 0.35882273 |
| 135 | EPHA3 | 0.32923706 |
| 136 | SGK2 | 0.32843079 |
| 137 | MAPK11 | 0.32506578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.02415127 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.58863614 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37957334 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28814960 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28230771 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11759097 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09388413 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04305953 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91157429 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85570531 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.82772384 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79356799 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.78416115 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.74312049 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74212724 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72917504 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68834901 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.63599387 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55823886 |
| 20 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.51662866 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51159142 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50530237 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46378603 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45308468 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.44503751 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39580833 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38302708 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.34530230 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.33753861 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28183362 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25562762 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23153221 |
| 33 | Colorectal cancer_Homo sapiens_hsa05210 | 1.21801178 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.21386901 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20939000 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.18519799 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.18449227 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18326556 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.16948093 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16521100 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.14806184 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.14481318 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14418887 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 1.12887898 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12578427 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09694959 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.08291794 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07932462 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06947725 |
| 50 | Mismatch repair_Homo sapiens_hsa03430 | 1.06433029 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.03852606 |
| 52 | Spliceosome_Homo sapiens_hsa03040 | 1.03339898 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02321505 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00907908 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99603088 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99237884 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98489703 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97633085 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97209906 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96910460 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96548893 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.93975024 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89111206 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.87841261 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86615365 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.84432452 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83269586 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82600636 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82454612 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81996911 |
| 71 | Pathways in cancer_Homo sapiens_hsa05200 | 0.81185333 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 0.80636288 |
| 73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80106554 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.79686568 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.78240517 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78083178 |
| 77 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76934294 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76610202 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76564913 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76372077 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75246843 |
| 82 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72740435 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.71846368 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69518650 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69393981 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68795195 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.68072584 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67586106 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67274296 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64766334 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63839795 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.63761451 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63264521 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63029446 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62435774 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.61384114 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61154656 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.61110643 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59773832 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59751987 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59333483 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.59169193 |
| 103 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56552209 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56378544 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55962631 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.54141285 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53787941 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53231879 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53161487 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52211499 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51971794 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.50697536 |
| 113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49781955 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49609841 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48815417 |
| 116 | RNA transport_Homo sapiens_hsa03013 | 0.48039384 |
| 117 | Homologous recombination_Homo sapiens_hsa03440 | 0.47578251 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47376365 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47031562 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46325387 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44005605 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43695226 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.43526579 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41889138 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41293562 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41184233 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39590539 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36760623 |

